Arena Investors’s Aspire Biopharma ASBP Stock Holding History

Arena Investors’s Portfolio ASBP Stock Details ASBP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-125	Closed	-$1.66M	–	28
2024 Q1	$1.66M	Hold	125	–	–	24.87%	2
2023 Q4	$1.64M	Hold	125	–	–	8.63%	5
2023 Q3	$1.75M	Hold	125	–	–	1.97%	18
2023 Q2	$1.57M	Buy	+125	New	+$1.57M	1.38%	23

Other funds holding ASBP

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Arena Investors's ASBP Position: Q2 2024 in Review

Arena Investors sold out of Aspire Biopharma (ASBP) in Q2 2024, closing a stake of 125 shares — an estimated $1.66M sold.

Arena Investors first reported a position in ASBP in Q2 2023 and held it in 4 quarters. The position peaked at $1.75M in Q3 2023. 3 funds tracked by Wall St. Rank hold ASBP as of Q2 2024.

Arena Investors reported no remaining Aspire Biopharma position as of Q2 2024 after selling out during the quarter.
Arena Investors sold 125 Aspire Biopharma shares in Q2 2024, an estimated $1.66M.
Arena Investors first reported a position in Aspire Biopharma in Q2 2023 and held it in 4 quarters.
Arena Investors's Aspire Biopharma position peaked at $1.75M in Q3 2023.
3 funds tracked by Wall St. Rank held Aspire Biopharma as of Q2 2024.

Based on Arena Investors's 13F filing for Q2 2024, filed 14 Aug 2024.